Summary
Updated Aug 31, 2026
Terry L. Evans is Chief Commercial Officer of FENNEC PHARMACEUTICALS INC. (FENC). 7 SEC Form 4 filings on record going back to 2024, most recently on 3 August 2026.
Recent Transactions
7Every recent SEC Form 4 transaction Terry L. Evans has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Terry L. Evans files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Southpoint Capital Advisors LP - $10.34M of FENC open-market activity in the last 12 months
- Robert Andrade - $884K of FENC open-market activity in the last 12 months
- Rosty Raykov - $856K of FENC open-market activity in the last 12 months
- Chris A. Rallis - $75K of FENC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Terry L. Evans?
Terry L. Evans is a corporate insider, tracked as Chief Commercial Officer of FENNEC PHARMACEUTICALS INC. (FENC). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Terry L. Evans submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Terry L. Evans's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Terry L. Evans and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
